Story detail view · 2026-07
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access

STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access

Quick Summary

The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.

Continue Reading on STAT News

Get instant updates on Telegram

Join our channel to receive the latest headlines and breaking stories as soon as they are published.

Join channel

Comments (0)

Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.

No comments yet. Be the first to share your thoughts!

Write a comment

0 / 500